vs
Side-by-side financial comparison of Prelude Therapeutics Inc (PRLD) and SOLAI Ltd (SLAI). Click either name above to swap in a different company.
SOLAI Ltd is the larger business by last-quarter revenue ($11.0M vs $6.5M, roughly 1.7× Prelude Therapeutics Inc). SOLAI Ltd runs the higher net margin — -126.2% vs -303.5%, a 177.3% gap on every dollar of revenue. On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs -43.1%).
PRLD vs SLAI — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.5M | $11.0M |
| Net Profit | $-19.7M | $-13.9M |
| Gross Margin | — | 0.1% |
| Operating Margin | -314.1% | -126.2% |
| Net Margin | -303.5% | -126.2% |
| Revenue YoY | 116.7% | -43.1% |
| Net Profit YoY | 38.9% | -173.4% |
| EPS (diluted) | $-0.26 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | $11.0M | ||
| Q3 24 | $3.0M | — | ||
| Q2 24 | — | $19.4M |
| Q3 25 | $-19.7M | — | ||
| Q2 25 | — | $-13.9M | ||
| Q3 24 | $-32.3M | — | ||
| Q2 24 | — | $18.9M |
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 52.4% |
| Q3 25 | -314.1% | — | ||
| Q2 25 | — | -126.2% | ||
| Q3 24 | -1145.9% | — | ||
| Q2 24 | — | -2.6% |
| Q3 25 | -303.5% | — | ||
| Q2 25 | — | -126.2% | ||
| Q3 24 | -1075.7% | — | ||
| Q2 24 | — | 97.9% |
| Q3 25 | $-0.26 | — | ||
| Q2 25 | — | $-0.01 | ||
| Q3 24 | $-0.43 | — | ||
| Q2 24 | — | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $55.0M | $1.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.5M | $43.8M |
| Total Assets | $94.8M | $69.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | $1.2M | ||
| Q3 24 | $153.6M | — | ||
| Q2 24 | — | $2.3M |
| Q3 25 | $58.5M | — | ||
| Q2 25 | — | $43.8M | ||
| Q3 24 | $156.4M | — | ||
| Q2 24 | — | $45.9M |
| Q3 25 | $94.8M | — | ||
| Q2 25 | — | $69.1M | ||
| Q3 24 | $197.2M | — | ||
| Q2 24 | — | $63.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-19.1M | $-17.0M |
| Free Cash FlowOCF − Capex | — | $-17.0M |
| FCF MarginFCF / Revenue | — | -154.2% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-19.1M | — | ||
| Q2 25 | — | $-17.0M | ||
| Q3 24 | $-27.3M | — | ||
| Q2 24 | — | $-12.1M |
| Q3 25 | — | — | ||
| Q2 25 | — | $-17.0M | ||
| Q3 24 | $-27.4M | — | ||
| Q2 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | -154.2% | ||
| Q3 24 | -912.0% | — | ||
| Q2 24 | — | — |
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | 0.0% | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRLD
Segment breakdown not available.
SLAI
| Data center | $6.5M | 59% |
| Cryptocurrency mining | $4.6M | 41% |
